Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Severe Crohn's Disease”

Showing 20 of 0 results

Testing effectiveness (Phase 2)Looking for participantsNCT01962415
What this trial is testing

Reduced Intensity Conditioning for Non-Malignant Disorders Undergoing UCBT, BMT or PBSCT

Who this might be right for
Primary Immunodeficiency (PID)Congenital Bone Marrow Failure SyndromesInherited Metabolic Disorders (IMD)+4 more
Paul Szabolcs 100
Testing effectiveness (Phase 2)Study completedNCT03854305
What this trial is testing

Phase 2a Study of PRV-6527 in Subjects With Moderately to Severely Active Crohn's Disease

Who this might be right for
Crohn's Disease
Provention Bio, Inc. 93
Large-scale testing (Phase 3)Study completedNCT00078611
What this trial is testing

A Clinical Trial of Natalizumab in Individuals With Moderately to Severely Active Crohn's Disease

Who this might be right for
Crohn's Disease
Biogen 462
Early research (Phase 1)Study completedNCT01258205
What this trial is testing

Multiple Ascending Doses of AMG 139 in Healthy and Crohn's Disease Subjects

Who this might be right for
Crohn's Disease
AstraZeneca 48
Large-scale testing (Phase 3)Ended earlyNCT03759288
What this trial is testing

An Active and Placebo-Controlled Study of Brazikumab in Participants With Moderately to Severely Active Crohn's Disease

Who this might be right for
Crohn's DiseaseIBD
AstraZeneca 89
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07753850
What this trial is testing

SL-325 in Crohn's Disease Patients

Who this might be right for
Crohn's Disease
Shattuck Labs, Inc. 232
Testing effectiveness (Phase 2)Ended earlyNCT03472690
What this trial is testing

QBECO SSI for Clinical and Endoscopic Remission in Moderate to Severe Crohn's Disease

Who this might be right for
Crohn Disease
Qu Biologics Inc. 20
Testing effectiveness (Phase 2)Study completedNCT00741910
What this trial is testing

Extension Study of Semapimod 60 mg IV x 3 Days

Who this might be right for
Crohn's Disease
Ferring Pharmaceuticals 15
Large-scale testing (Phase 3)Study completedNCT00409617
What this trial is testing

Study of Adalimumab Treatment for Induction and Maintenance of Clinical Remission in Subjects With Crohn's Disease

Who this might be right for
Crohn's Disease
Abbott 945
Early research (Phase 1)WithdrawnNCT05028946
What this trial is testing

Oral Foralumab in Participants With Moderate to Severely Active Crohn's Disease

Who this might be right for
Crohn's Disease
Tiziana Life Sciences LTD
Testing effectiveness (Phase 2)Study completedNCT00737932
What this trial is testing

Laquinimod Phase IIa Study in Active Crohn's Disease

Who this might be right for
Crohn's Disease
Teva Branded Pharmaceutical Products R&D, Inc. 180
Large-scale testing (Phase 3)Ended earlyNCT00307931
What this trial is testing

Certolizumab Pegol for Treatment of Adult Greek Patients With Moderate to Severe Crohn's Disease Who Failed Infliximab

Who this might be right for
Crohn's Disease
UCB Pharma 16
Large-scale testing (Phase 3)Study completedNCT00482092
What this trial is testing

Evaluation of PROCHYMAL® Adult Human Stem Cells for Treatment-resistant Moderate-to-severe Crohn's Disease

Who this might be right for
Crohn's Disease
Mesoblast, Inc. 330
Testing effectiveness (Phase 2)WithdrawnNCT05471492
What this trial is testing

Study to Evaluate the Efficacy and Safety of PF-06480605 in Adult Participants With Moderate to Severe Crohn's Disease

Who this might be right for
Crohn Disease
Telavant, Inc.
Large-scale testing (Phase 3)Study completedNCT02611817
What this trial is testing

Efficacy and Safety of Vedolizumab Subcutaneous (SC) as Maintenance Therapy in Crohn's Disease (CD)

Who this might be right for
Crohn's Disease
Takeda 644
Large-scale testing (Phase 3)Study completedNCT01224171
What this trial is testing

Study of Vedolizumab in Patients With Moderate to Severe Crohn's Disease

Who this might be right for
Crohn's Disease
Millennium Pharmaceuticals, Inc. 416
Large-scale testing (Phase 3)Looking for participantsNCT07577843
What this trial is testing

JNJ-78934804 in Participants With Moderately to Severely Active Crohn's Disease

Who this might be right for
Crohn Disease
Janssen Research & Development, LLC 460
Large-scale testing (Phase 3)Study completedNCT00552344
What this trial is testing

Evaluate Safety of Long Term Therapy of Certolizumab Pegol Patients With Crohn's Disease

Who this might be right for
Crohn Disease
UCB BIOSCIENCES GmbH 403
Large-scale testing (Phase 3)Looking for participantsNCT04779320
What this trial is testing

Vedolizumab in Children and Teenagers With Moderate to Severe Crohn's Disease (CD)

Who this might be right for
Crohn's Disease (CD)
Takeda 120
Not applicableStudy completedNCT04873700
What this trial is testing

Moderate to Severe Inflammatory Bowel Disease, Including Ulcerative Colitis (UC) and Crohn's Disease (CD)

Who this might be right for
Inflammatory Bowel DiseasesColitis, UlcerativeCrohn Disease
Takeda 335
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation